Back to
JPMORGAN CHASE & COKYKYNB
KYKYNB5 quarters
Position history for
JPMORGAN CHASE & CO's holdings in KYNTRA BIO INC
Yes. JPMorgan Chase holds 12 shares of KYNB (Kyntra Bio), worth $88, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. JPMorgan Chase has held KYNB in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$88
Current Shares
12
Total Value Change
+$24
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of KYNB: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.